TERN-701 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt

Representative image of a large precious metals mining operation, illustrating the Fresnillo plc share price surge as investors weigh whether the FTSE 100 miner’s 2026 guidance cut is a temporary pause in the silver and gold bull run.

Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?

Representative image of commercial shipping and naval activity in the Strait of Hormuz, as Iran reopens the key oil transit route while uncertainty over the United States naval blockade continues.

Strait of Hormuz reopens on paper, yet ships turn back as Iran and US clash over blockade terms

TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record

Representative image of a leukemia drug development and biopharma acquisition theme, illustrating why Merck’s $6.7bn Terns Pharmaceuticals deal and TERN-701 are drawing attention as the Keytruda patent cliff approaches.

Read More

Pharma Industry News

Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears

Merck agrees to acquire Terns Pharmaceuticals for $6.7B, adding TERN-701 CML drug to its oncology pipeline ahead of Keytruda's 2028 patent cliff. Read the full analysis.

March 26, 2026

web analytics